Studies have shown conflicting results about the association between DNMTs polymorphisms (DNMT1, DNMT3A, DNMT3B) and gastric cancer (GC) risk. The study aims to assess the impact of these polymorphisms on GC susceptibility. This evidence concerns the gene DNMT3B and gastric cancer.